Amarin Corporation PLC

Amarin Corporation PLC is a biopharmaceutical company dedicated to developing and commercializing therapies aimed at improving cardiovascular health globally. The company's flagship product, Vascepa, is an FDA-approved prescription fish oil derivative used to reduce the risk of major cardiovascular events in adults with elevated triglyceride levels. Amarin focuses on expanding its portfolio of cardiovascular treatments through ongoing research and development, targeting conditions such as heart disease and stroke. By leveraging scientific advancements and strategic collaborations, Amarin seeks to provide cost-effective solutions that address unmet needs in cardiovascular disease management, ultimately aiming to enhance patient outcomes and reduce the global burden of heart-related illnesses.